Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Belimumab concentration measurements using a homologous anti-idiotype immunoassay.
Loeff FC, Parodis I, Walhelm T, Jönsen A, Nikolopoulos D, Sjöwall C, Bengtsson AA, Kos D, van Leeuwen A, van den Broek B, Dijk L, Jeremiasse J, Blomjous BS, Voskuyl AE, Wolbink GJ, Bultink IEM, Rispens T. Loeff FC, et al. J Immunol Methods. 2024 Sep;532:113717. doi: 10.1016/j.jim.2024.113717. Epub 2024 Jul 2. J Immunol Methods. 2024. PMID: 38960066
Patient-perspective and feasibility of home finger-prick testing to complement and facilitate large-scale research in rheumatology.
Besten YR, Boekel L, Steenhuis M, Hooijberg F, Atiqi S, Leeuw M, Vogelzang EH, Keijser J, Keijzer S, Loeff FC, Gerritsen M, Tas SW, Nurmohamed MT, Rispens T, Wolbink G. Besten YR, et al. Among authors: loeff fc. RMD Open. 2024 Apr 19;10(2):e003933. doi: 10.1136/rmdopen-2023-003933. RMD Open. 2024. PMID: 38642927 Free PMC article.
Clinical Validation of a Capillary Blood Home-Based Self-Sampling Technique for Monitoring of Infliximab, Vedolizumab, and C-Reactive Protein Concentrations in Patients With Inflammatory Bowel Disease.
Otten AT, van der Meulen HH, Steenhuis M, Loeff FC, Touw DJ, Kosterink JGW, Frijlink HW, Rispens T, Dijkstra G, Visschedijk MC, Bourgonje AR. Otten AT, et al. Among authors: loeff fc. Inflamm Bowel Dis. 2024 Mar 1;30(3):325-335. doi: 10.1093/ibd/izad103. Inflamm Bowel Dis. 2024. PMID: 37265165 Free PMC article.
Optimization of a Quantitative Anti-Drug Antibodies against Infliximab Assay with the Liquid Chromatography-Tandem Mass Spectrometry: A Method Validation Study and Future Perspectives.
Smeijsters EH, van der Elst KCM, Visch A, Göbel C, Loeff FC, Rispens T, Huitema ADR, van Luin M, El Amrani M. Smeijsters EH, et al. Among authors: loeff fc. Pharmaceutics. 2023 May 12;15(5):1477. doi: 10.3390/pharmaceutics15051477. Pharmaceutics. 2023. PMID: 37242719 Free PMC article.
Development of antidrug antibodies against adalimumab maps to variation within the HLA-DR peptide-binding groove.
Tsakok T, Saklatvala J, Rispens T, Loeff FC, de Vries A, Allen MH, Barbosa IA, Baudry D, Dasandi T, Duckworth M, Meynell F, Russell A, Chapman A, McBride S, McKenna K, Perera G, Ramsay H, Ramesh R, Sands K, Shipman A; Biomarkers of Systemic Treatment Outcomes in Psoriasis (BSTOP) Study Group; Burden AD, Griffiths CE, Reynolds NJ, Warren RB, Mahil S, Barker J, Dand N, Smith C, Simpson MA. Tsakok T, et al. Among authors: loeff fc. JCI Insight. 2023 Feb 22;8(4):e156643. doi: 10.1172/jci.insight.156643. JCI Insight. 2023. PMID: 36810251 Free PMC article.
25 results